INWOOD LABS
GenericsINWOOD LABS is a generic drug manufacturer focused on Cardiovascular, Neurology, Gastroenterology.
INWOOD LABS's Key Drugs
INWOOD LABS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
INWOOD LABS's Recent FDA Approvals
New NDA/BLA approvals for INWOOD LABS over the last two years — novel drugs only, excluding generics and label supplements.
INWOOD LABS's Therapeutic Areas
INWOOD LABS's approved drugs and pipeline span 3 therapeutic areas, led by Cardiovascular and Neurology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
INWOOD LABS's Top Competitors
INWOOD LABS's closest competitors by therapeutic-area and drug-target overlap include VALIDUS PHARMS, WARNER CHILCOTT, and Bristol-Myers Squibb. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
INWOOD LABS Pipeline Snapshot
Active clinical trials for INWOOD LABS across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1971-12-23
- Latest
- 2002-02-12
- Applications
- 25